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Using estimated probability of pre-
diagnosis behavior as a predictor of cancer
survival time: an example in esophageal
cancer
Paul P. Fahey1,2*, Andrew Page2, Glenn Stone3 and Thomas Astell-Burt4
Abstract
Background: Information on the associations between pre-diagnosis health behavior and post-diagnosis survival
time in esophageal cancer could assist in planning health services but can be difficult to obtain using established
study designs. We postulated that, with a large data set, using estimated probability for a behavior as a predictor of
survival times could provide useful insight as to the impact of actual behavior.
Methods: Data from a national health survey and logistic regression were used to calculate the probability of
selected health behaviors from participant’s demographic characteristics for each esophageal cancer case within a
large cancer registry data base. The associations between survival time and the probability of the health behaviors
were investigated using Cox regression.
Results: Observed associations include: a 0.1 increase in the probability of smoking 1 year prior to diagnosis was
detrimental to survival (Hazard Ratio (HR) 1.21, 95% CI 1.19,1.23); a 0.1 increase in the probability of hazardous
alcohol consumption 10 years prior to diagnosis was associated with decreased survival in squamous cell cancer
(HR 1.29, 95% CI 1.07, 1.56) but not adenocarcinoma (HR 1.08, 95% CI 0.94,1.25); a 0.1 increase in the probability of
physical activity outside the workplace is protective (HR 0.83, 95% CI 0.81,0.84).
Conclusions: We conclude that probability for health behavior estimated from demographic characteristics can
provide an initial assessment of the association between pre-diagnosis health behavior and post-diagnosis health
outcomes, allowing some sharing of information across otherwise unrelated data collections.
Keywords: Esophageal cancer, Survival, Health behavior, Tobacco, Alcohol, Physical activity
Background
With an incidence of 9.3/100,000 males and 3.5/100,000
females per year, esophageal cancer led to more than half
a million deaths worldwide in 2018 [1]. The majority of
these deaths arise from modifiable lifestyle factors. In the
US in 2014 it was estimated that 71% of male and 59% of
female esophageal cancer deaths arose from modifiable
lifestyle factors and that cigarette smoking, alcohol con-
sumption and excess body weight could account for up to
50, 17 and 27% of deaths respectively [2].
While there is considerable documentation of associa-
tions between health behavior and onset of esophageal
cancer [3], the impact of health behavior on survival
times is less well understood [4]. A more thorough un-
derstanding of predictors of survival time is needed to
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assist in anticipating health service needs and for health
services planning.
Health behavior prior to a cancer diagnosis is often
different from health behavior post-diagnosis. Behavior
prior to diagnosis can be influenced by public health ac-
tivity but post-diagnosis behavior is strongly influenced
by the diagnosis itself [5] and by treatment [6, 7]. As
esophageal cancer has relatively short survival times (in
the US, just 19% of cases survive 5-years [8]), pre-
diagnosis behavior could have a strong carry over effect
on survival time.
Unfortunately, investigating the effect of pre-
diagnosis behavior on post-diagnosis survival can be
difficult and expensive. As the disease is relatively
rare, a prospective cohort study would be inefficient
(on the figures above, surveillance of 100,000 men for
10 years would be expected to yield just 93 new
esophageal cancer cases). Retrospective studies which
enroll newly diagnosed cancer patients and ask them
to recall their prior health behavior still involve con-
siderable expense and are fraught with recall and sur-
vivor biases. In one example, an Australian study
enrolling newly diagnosed esophageal cancer patients
reported that patients with late-stage disease were dif-
ficult to enroll and under-represented [9].
Secondary analyses of already existing data can provide
alternate, cost-effective opportunities. It is now common
for governments to sponsor both regular health behavior
surveys and mandatory cancer registries. For those can-
cer cases who contributed to a survey prior to diagnosis,
their health behavior and cancer outcomes can be linked
to produce a retrospective cohort. Data linkage avoids
recall and survivor biases and is cost efficient (as the re-
quired data are already collected, compiled and cleaned).
But data linkage may not be feasible either. Confiden-
tiality is one issue. But more fundamentally, as esopha-
geal cancer is relatively rare, the number of cancer cases
who happened to have previously participated in the
health survey is likely to be very small. If data linkage
cannot be applied, is there any other way in which these
rich (and expensive) data sets can be used to help pro-
vide insights into the association between pre-diagnosis
behavior and post-diagnosis survival times?
Often the only measures in common between cancer
registries and national health surveys are the demo-
graphic characteristics of participants. It is known that
demographically similar people are more likely to display
similar health behavior than people from different
demographic groups [10]. That is, different demographic
groups have a different likelihood for particular behav-
iors. Probability of behavior calculated from demo-
graphic variables, may be a weak indicator of actual
behavior, but with large data sets even weak signals are
detectable.
This study investigated whether or not useful informa-
tion on the association between pre-diagnosis health be-
haviors and post-diagnosis survival times could be
obtained by analyzing cancer cases estimated probability
of engaging in these behaviors. The analyses used US
data and focused mainly on the three modifiable lifestyle
factors identified above: cigarette smoking, alcohol con-
sumption and excess body weight.
Methods
The data sets
Unit record data on esophageal cancer cases and their
outcomes was extracted from the Surveillance, Epidemi-
ology, and End Results Program (SEER) cancer registry
[11]. The SEER system is administered by the National
Cancer Institute. SEER currently compiles data from
cancer registries covering about 28% of the US popula-
tion across 13 States. Most cancers, including esophageal
cancers, are recorded. De-identified unit record data
made available for research include demographic mea-
sures, medical details of the cancer, treatment and out-
comes (including survival time). 95.1% of esophageal
cases had positive histology with just 0.4% clinical diag-
nosis only; the remainder having unknown (2.4%) or
other confirmation methods.
Data on health behavior was extracted from the Be-
havioral Risk Factor Surveillance System (BRFSS) health
survey [12]. The BRFSS is an annual national survey of
health. It commenced in 1984 and now collects data
from more than 400,000 telephone interviews each year
covering adult residents of all US States and three Terri-
tories. The de-identified unit record information made
available for research included demographic and health
behavior measures, and State population sampling
weights.
Both collections provided access to cleaned, de-
identified unit record data at no cost to the researcher.
Although both data collections are large, with less than
0.2% of American adults participating in BRFSS and
around 4000 esophageal cancer cases being recorded in
the SEER data set each year, we could only expect about
eight new esophageal cancer cases each year to have par-
ticipated in the previous BRFSS survey.
Inclusions and exclusions
This analysis focusses on the 15-year period from 2001
to 2015. Data prior to 2001 are excluded due to changes
in the definitions of some health behaviors variables and
because earlier data may be less relevant to current be-
havior and outcomes. 2015 was the most recent year of
SEER cancer registry data.
As esophageal cancer is rare in young ages, all cancer
cases who were less than 35 years of age are excluded as
being atypical. Two hundred one of 57,025 (0.3%) cases
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are excluded. For the BRFSS health survey, all data re-
cords from respondents 25 or more years of age who
lived in one of the 13 US States represented in the SEER
cancer registries are included. Including the younger re-
spondents allows information on health behavior up to
10 years prior to cancer diagnosis to be retained.
Outcome variable
The outcome of interest is post-diagnosis survival
time in months as recorded in the SEER cancer regis-
try data set. That is, all cases with survival less than
30.4 days after diagnosis (including cancers detected
post-mortem) have a survival time of 0 months, those
who died between 30.4 and 60.8 days have a survival
time of 1 month, etc. The maximum possible survival
time is 179 months. For those who are still alive and
those who are lost to follow-up, survival time is cen-
sored at the date of last follow-up.
Health behavior variables
The research focused mainly on measures relating to
cigarette smoking, alcohol consumption and excess body
weight. The choice of variables was restricted to mea-
sures available through the BRFSS health survey. The
following variables, all recording self-reported behavior,
were included:
 Current smoker (yes/no) which includes those who
smoke daily or less than daily;
 Alcohol - heavy drinking (yes or no), which is
defined as more than two standard drinks per day
for men and more than one standard drink per day
for women in the month prior to survey;
 Alcohol - binge drinking (yes or no), which is
defined as males reporting having five or more
standard drinks or females reporting 4 or more
standard drinks on one occasion in the month prior
to survey;
 Current smoking and alcohol consumption (yes/no),
which is defined as both current smoker and an
average consumption of ≥1 standard drink of
alcohol per day in the past month.
 Obese (yes/no) which is BMI ≥ 30 kg/m2
 Undertook physical activity or exercise in the past
30 days other than regular job (yes or no)
Demographic variables
As the cancer registry data did not include informa-
tion on pre-diagnosis health behavior we estimated
the probability of each pre-diagnosis health behavior
for each cancer case using the available demographic
variables.
Of the variables in common between the SEER
cancer registry and the BRFSS health surveys we
hypothesized that year, age, sex, race, marital status
and State of residence could be helpful for predict-
ing health behavior. For example, race is known to
be associated with smoking [13] and alcohol depend-
ence [14] in the US. Also, living as married amelio-
rates social isolation and social isolation is associated
with adverse health behaviors such as smoking,
higher BMI, and lower desire for exercise [15].
As age was recorded in 5-year age groups in the
SEER cancer registry data, we applied the same cat-
egories to the BRFSS health survey data. Race was
categorized as White; Black; Asian or Pacific Islander;
and American Indian or Alaskan native. Participants
in the BRFSS health survey who self-reported as
mixed race (n = 44,670, 3.1% of total) were omitted as
there was no corresponding code in the SEER cancer
registry data set. Marital status was categorized as
married or living as married; divorced or separated;
widowed; and single.
Other factors considered
Post-diagnosis survival time is sensitive to a range
of factors, some of which could potentially con-
found associations with pre-diagnosis health behav-
ior and survival time. For example, the association
between health behaviors and incidence of esopha-
geal cancer is known to differ by histological type
[3, 16] and these differences appear to carry over
into survival time [17, 18]. Therefore, we have con-
ducted sub-group analyses for squamous cell car-
cinoma (ESCC) and adenocarcinoma (EAC). Also
age is associated with survival time [19] and health
behavior can change with age. Age, recorded in 5-
year age groups but treated as a continuous vari-
able, is included in the final models as a potential
confounder.
Somewhat more difficult was how to address cancer
stage. Cancer stage at diagnosis is an important pre-
dictor of survival time [19] and could perhaps be as-
sociated with health behavior, although this
association may be an intermediary step between
health behavior and survival time rather than a true
confounder. For completeness we opted to adjust for
cancer stage in our models. Disease stage at diagnosis
(clinical assessment) was coded by SEER according to
the according to the AJCC Cancer Staging Manual
6th Edition [20].
Recording of cancer stage at diagnosis was incom-
plete in the SEER cancer registry data; being unavail-
able from 2001 to 2003 and having 18% missing data
across the other years. We have excluded cancer stage
prior to 2004 and categorized it into 5 categories
(stage I, stage II, stage III, stage IV, not specified)
from 2004 onwards.
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Other potential confounders of the association be-
tween behavior and survival were considered to be of
lesser impact or potentially on the disease pathway.
For example, while the relationship between smoking
history and post-diagnosis survival may differ by gen-
der, the effect may be small. In contrast, the choice
between curative or palliative treatment is a strong
predictor of survival time but may partially lie on the
association pathway. (Smoking, for example, may lead
to a higher probability of significant co-morbidities
and these in turn influence the decision of curative
treatment and, hence, survival time.) Adjustment for
variables on the association pathway may remove
some of the true association between health behavior
and survival time.
Eligible data records
Fifty-six thousand eight hundred twenty-four SEER
esophageal cancer cases and 1,450,775 BRFSS health sur-
vey respondents met the eligibility criteria. Add-
itional file 1 summarizes the characteristics of the two
samples. Among the cancer cases, median time till death
was 7 months with median follow-up time of censored
observations (18.6%) was 30months. 52.9% of cases were
EAC and 33.7% ESCC. 16.1% of the BRFSS respondents
were current smokers and 4.8% were judged to be heavy
drinkers of alcohol. The BRFSS respondents included
higher proportions of younger people and females than
the SEER cases.
Statistical analysis
The characteristics of eligible cancer registry cases and
health survey respondents are summarized using counts
and percentages, with the exception of survival time
which is summarized using medians, quartiles and
maximums.
The main analysis involves three discrete steps.
Firstly, the probability of engaging in each health be-
havior were estimated from the BRFSS health survey
data using logistic models; with a separate model for
each behavior. Each modelled the probability of hav-
ing the behavior of interest based on year of survey,
age, sex, race, marital status and State of residence.
We also allowed for differences in the probability of
health behaviors between sexes and between marital
statuses at different ages by including age by sex, age
by marital status and marital status by sex interaction
terms in each logistic model.
For example, if we let i represent an eligible individual
from the BRFSS data set and dpiðsmokerÞ represent the
estimated probability that person i is a smoker, then the
logistic model has the form
logit dpi smokerð Þ
 
¼ xiβ^ ð1Þ
where
xiβ^ ¼ bβ0 þ bβ1 yearið Þ þ bβ2 agei
 þ bβ3 sexið Þ
þ dβ4−6 raceið Þ þ bβ7 marital statusið Þ
þ dβ8−19 State of residenceið Þ þ cβ20 agei
 
sexið Þ
þ cβ21 agei
 
marital statusið Þ þ cβ22 sexið Þ
 marital statusið Þ
and the β^ ’s quantify the relationships between the
demographic characteristics of the respondents and their
likelihood of smoking.
To correct for the complexities in the BRFSS health
survey sampling and non-response we weighted the lo-
gistic models by the sampling weights provided. In 2011,
the BRFSS introduced a new method of calculating sam-
pling weights which improved the weighting of some
variables including race and marital status. However, as
both systems weight to the State totals, we do not differ-
entiate between the different type of weights in this ana-
lysis. We excluded data records with extreme sampling
weights: those which fell in either the top or bottom
0.5% of the distribution. To assist the models to con-
verge we use Firth’s bias reduced penalized-likelihood
when fitting the models; using the logistf package (ver-
sion 1.23) in R software (version 3.5.2). The fitted
models are summarized in Additional file 5.
Year and age category were fitted as numeric variables
while sex, race, marital status and State of residence are
categorical. Preliminary investigations (not reported)
confirmed that a linear model was reasonable for both
year and age category. Year is coded as 0 for 2001
through to 14 for 2015 for analysis.
We confirmed that the chosen risk profiling variables
were indeed predictors of each health behavior by visual
inspection of odds ratios from logistic regression models.
To help gauge the predictive ability of each demographic
variable we present areas under the curve (AUC) of the
receiver operating characteristic (ROC) curve for each
predictor alone and for the full logistic model using the
pROC package (version 1.13.0) in R software. The higher
above 0.5 the AUC, the greater the ability of the model
to predict the health behavior.
In the second step of the analysis, for each esophageal
cancer case in the SEER cancer registry, we estimated
their probability of participating in each health behavior
by substituting their demographic characteristics into
the logistic predictive model for that behavior.
For example, if we let j represent an eligible cancer
case from the SEER data set and xj the set of observed
values of the demographic variables for individual j and
β^ represent the regression coefficients for the model pre-
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dicting smoking (eq. 1 above), then we estimated the
probability of cancer case j being a smoker as
dpj smokerð Þ ¼
ex jβ^
1þ ex j β^
ð2Þ
As we were specifically interested in health behavior
prior to diagnosis we trialed three pre-diagnosis time
points: 1, 5 and 10 years prior to diagnosis. This entailed
substituting diagnosis year minus 1, 5 or 10 as the year
variable of the logistic model and 5-age group minus 0,
1 or 2. To avoid extrapolating earlier than the observed
data, the 5-year lag analysis was restricted to esophageal
cancer cases from 2006 to 2015 and the 10-year lag
model was restricted to cases from 2011 to 2015.
In the third step of the analysis, the relationship be-
tween the estimated probability of each behavior and
survival was investigated using Cox regression models
using the survival package (version 2.43–3) in R soft-
ware. Separate models were fitted for each behavior. Re-
sults are presented as hazard ratios (HRs) with
associated 95% confidence intervals (CIs) and p-values.
Models were fitted with and without correction for age
and cancer stage at diagnosis.
For example, the Cox model of survival time of cancer
case j relative to their estimated probability of smoking,
adjusting for age and disease stage, could be written
S t; x; βð Þ ¼ S0 tð Þ½ 
exp β1 dp j smokerð Þ
 
þβ2 age jð Þþβ3 cancer stage jð Þ
 
ð3Þ
where dpjðsmokerÞ, a number between 0 and 1, is the esti-
mated probability that the SEER cancer case is a smoker
from Eq. (2). The * superscript is just to highlight that
these β ’s are different to the β ’s listed in Eq. (1). Under
this model eβ

1 is the hazard ratio for the estimated prob-
ability of smoking, adjusted for age and disease stage.
Subgroup analyses were performed for ESCC and EAC
histological types. Missing values were excluded from
analysis.
Results
Each of the risk profile variables were related to each of
the health behaviors [see Additional file 2]. For example,
the prevalence of smoking decreased over the study
period (odds ratio (OR) = 0.98, 95% confidence interval
(CI) 0.98–0.98 for each later year); the prevalence of
obesity increased over time (OR = 1.03, 95% CI 1.03–
1.03 for each additional year); each 5-year increase in
age is associated with decreasing prevalence of smoking
(OR = 0.90, 95% CI 0.90–0.90) and decreased risk of
binge drinking (OR = 0.82, 95% CI 0.82–0.82); females
have lower prevalence of smoking (OR = 0.74, 95% CI
0.74,0.74); when compared to those who are married,
people who are single have higher prevalence of daily
smoking (OR = 2.14, 95% CI 2.14–2.14), risk of binge
drinking (OR = 1.90, 95% CI 0.90–0.90) and risk of con-
currently smoking and regular drinking (OR = 2.50, 95%
CI 2.50–2.50); people classifying as American Indian or
Alaskan Native have higher prevalence of daily smoking
(OR = 1.69, 95% CI 1.68–1.69) and people classified as
black have higher risk of obesity (OR = 1.75, 95% CI
1.75–1.75) than those who are classified as white; resi-
dents of Kentucky are more likely to smoke (OR = 2.50,
95% CI 2.49–2.50) residents of Utah are less likely to be
heavy drinkers (OR = 0.52, 95% CI 0.52–0.52) than
Californians.
Of the fitted logistic models, the model predicting
binge drinking (AUC 0.74) appeared most accurate and
the model for predicting obesity (AUC 0.59) appeared
least accurate.
Table 1 shows the associations between post-diagnosis
survival time and probability of each pre-diagnosis
health behavior. Each line presents results from separate
Cox regression models; for each health behavior. The
columns present results from three separate models: the
unadjusted model with the probability of behavior 1 year
prior to diagnosis as the only predictor; the one-year lag
model adjusted for age and cancer stage at diagnosis;
and the adjusted model with a 10-year lag. The hazard
ratios reported show the impact of a 0.1 increase in the
probability of participating in that behavior. Tables 2
and 3 provide the same results for the ESCC and EAC
histological types separately. Both adjusted variables (age
and cancer stage at diagnosis) are significant predictors
of survival [see Additional file 3]. Result for the 5-year
lag model [see Additional file 4] are similar to corre-
sponding one-year lag models shown.
Smoking 1 year prior to diagnosis appears to be unre-
lated to survival until adjustment for age and disease
stage at diagnosis. In the adjusted model, each 0.1 in-
crease in the probability of pre-diagnosis smoking is as-
sociated with a 20% (HR 1.20, 95% CI 1.18–1.22)
increase in post-diagnosis hazard with no discernible dif-
ference in results for ESCC and EAC subgroups.
Results for alcohol consumption are mixed. When
using behavior 1 year prior to diagnosis as the predictor,
a 0.1 increase in the probability of heavy drinking ap-
pears to be protective of survival even after adjustment
for age and cancer stage at diagnosis (HR 0.82, 95% CI
0.76–0.88). However, when looking at behavior 10 years
prior to diagnosis, the adjusted model finds heavy drink-
ing to be detrimental to post-diagnosis survival in ESCC
(HR 1.30, 95% CI 1.08–1.57) and with no discernable as-
sociation in EAC (HR 1.10, 95% CI 0.95–1.26). The pat-
tern of results for binge drinking is quite similar.
A 0.1 increase in the probability of concurrently smok-
ing and drinking ≥1 standard drink per day in the year
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prior to diagnosis is associated with double the risk of
death (HR = 1.93, 95% CI 1.79–2.07), after adjustment
for age and cancer stage with no difference between
ESCC and EAC.
After adjustment, a 0.1 increase in probability of obese
1 year prior to diagnosis is associated with an apparently
trivial increase in post-diagnosis hazard (HR 1.04, 95%
CI 1.03–1.06). A slightly larger hazard (HR 1.10, 95% CI
1.07–1.14) was recorded for a 0.1 increase in the prob-
ability of obese 10 years prior to diagnosis. A 0.1 increase
in the probability of exercise outside employment 1 year
prior to diagnosis is associated with improved survival
(HR 0.82, 95% CI 0.81–0.84) with little difference be-
tween ESCC and EAC.
Discussion
The results above appear to support of the proposition
that demographic-derived estimates of the probability of
health behaviors can assist in identifying association be-
tween pre-diagnosis health behavior and post-diagnosis
survival time in esophageal cancer. The hazard ratios
quoted in this paper show the increased hazard of death
associated with each additional 0.1 probability of the
health behavior of interest. That is, we are reporting the
association between the estimated likelihood of engaging
in a particular behavior and survival time. This is quite
different from the association between the actual health
behavior and survival time and more difficult to inter-
pret. Never-the-less, there is consistency between the re-
sults of the present study and previously published
results: especially in the presence and direction of
associations.
We have found that a 0.1 increase in the probability of
smoking 1 year prior to diagnosis, adjusted for age and
cancer stage at diagnosis, had an estimated HR of 1.20
(95% CI 1.18–1.22) in esophageal cancer survival. This
association is consistent with findings from previous
meta analyses such as HR 1.41 (95% CI 1.22,1.64) [21]
for smoking status at time of diagnosis in mainly ESCC
patients and HR 1.19 (95% CI 1.04,1.36) for ever smok-
ing [4] in ESCC (although no evidence of association in
EAC). Some more recently published studies found simi-
lar statistically significant HRs including HR = 1.28 [22]
and HR = 1.34 [23] both from China, and HR = 1.22
from a study across two sites in US and Canada [24]. In
contrast, recent results from Japan HR = 0.97 [25] failed
to find evidence of association between pre-diagnosis
smoking and post-diagnosis survival time. A study from
South Africa reported an unadjusted HR = 0.92 [26] but
the present study has shown the importance of adjust-
ment for confounders such as age and cancer stage at
diagnosis.
Table 1 Association Between Survival Time and Probability of Pre-Diagnosis Health Behavior; All Esophageal Cancers
1 year lag, unadjusted 1 year lag, adjustedb 10 year lag, adjustedb
Health behavior HRa 95% CI P value HRa 95% CI P value HRa 95% CI P value
Current smoker 0.99 0.99,1.01 0.252 1.20 1.18,1.22 < 0.001 1.18 1.15,1.21 < 0.001
Alcohol - Heavy drinking 0.53 0.50,0.56 < 0.001 0.82 0.76,0.88 < 0.001 1.16 1.04,1.30 0.011
Alcohol - Binge drinking 0.76 0.74,0.77 < 0.001 0.96 0.93,0.99 0.012 1.04 0.99,1.08 0.093
Current smoking and alcohol consumption 0.87 0.83,0.92 < 0.001 1.93 1.79,2.07 < 0.001 1.69 1.56,1.84 < 0.001
Undertook exercise in past 30 days other than regular job 0.78 0.77,0.79 < 0.001 0.82 0.81,0.84 < 0.001 0.80 0.78,0.83 < 0.001
Obese 0.95 0.94,0.97 < 0.001 1.04 1.03,1.06 < 0.001 1.10 1.07,1.14 < 0.001
Abbreviations: CI Confidence interval, HR Hazard ratio
aThe hazard ratio describes the impact of a 0.1 increase in the probability of having the specified health behavior
bAdjusted for age and cancer stage at diagnosis
Table 2 Association Between Survival Time and Probability of Pre-Diagnosis Health Behavior; Esophageal Squamous Cell Carcinomas
Health behavior 1 year lag, unadjusted 1 year lag, adjustedb 10 year lag, adjustedb
HRa 95% CI P value HRa 95% CI P value HRa 95% CI P value
Current smoker 0.99 0.97,1.01 0.215 1.20 1.17,1.23 < 0.001 1.19 1.16,1.22 < 0.001
Alcohol - Heavy drinking 0.50 0.45,0.56 < 0.001 0.78 0.69,0.88 < 0.001 1.30 1.08,1.57 0.007
Alcohol - Binge drinking 0.75 0.73,0.78 < 0.001 0.95 0.90,1.00 0.035 1.09 1.02,1.17 0.013
Current smoker and≥ 1 alcoholic drink /day 0.85 0.79,0.93 < 0.001 1.93 1.72,2.16 < 0.001 1.68 1.51,1.88 < 0.001
Did exercise in past 30 days other than regular job 0.78 0.76,0.79 < 0.001 0.82 0.80,0.85 < 0.001 0.79 0.77,0.82 < 0.001
Obese 0.97 0.94,0.99 0.004 1.07 1.04,1.10 < 0.001 1.08 1.04,1.11 < 0.001
Abbreviations: CI Confidence interval, HR Hazard ratio
aThe hazard ratio describes the impact of a 0.1 increase in the probability of having the specified health behavior
bAdjusted for age and cancer stage at diagnosis
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The current analyses found that increased probability
for ‘at risk’ alcohol consumption in the year prior to
diagnosis were generally protective of survival but that a
0.1 increase in ‘at risk’ alcohol behavior 10 years prior to
diagnosis was detrimental to survival in ESCC (heavy
drinking HR 1.30 95% CI 1.08–1.57, binge drinking HR
1.09, 95% CI 1.02–1.17). The 10 year results are consist-
ent with a previous meta-analysis [4] which found that
ever drinking alcohol produced a significant increase in
hazard (HR 1.36, 95% CI 1.15, 1.61) in ESCC but non-
significant HR of 1.08 (95% CI 0.85, 1.37) in EAC al-
though ever drinking and ‘at risk’ drinking are widely
separate. More recent results from China HR = 1.58 [22],
HR = 1.45 [23] and Japan HR = 2.37 (95% CI 1.24,4.53)
[25] also support the detrimental impact of pre-
diagnosis alcohol consumption on post-diagnosis
survival.
The unexpectedly protective result for alcohol con-
sumption one-year prior to diagnosis could indicate in-
sufficient adjustment for confounding (such as
comorbidities or health symptoms) or weaknesses in the
measurement tool (such as biases in the self-reporting of
alcohol consumption in standard drinks).
Previous authors have found that pre-diagnosis smok-
ing and alcohol consumption combined produce a dis-
proportionately high risk to post-diagnosis survival (for
example, HR 3.84, 95% CI 2.02,7.32 for ESCC [17]). We
have also found that a 0.1 increase in the probability of
concurrent daily smoking and consuming one or more
alcoholic drinks per day 1 year prior to diagnosis, ad-
justed for age and cancer stage at diagnosis, had a rela-
tively high estimated HR of 1.93 (95% CI 1.79,2.07).
We observed that a 0.1 increase in the probability of
obese 1 year prior to diagnosis was associated with
slightly higher risk of death adjusted HR = 1.04 (95% CI
1.03,1.06) mainly associated with ESCC (HR 1.07 95% CI
1.04,1.10). The association seems small and the literature
on obesity is sparse with mixed findings. One review
found pre-diagnosis obesity could be associated with
higher risks of death in cancer (specifically breast,
prostate and colorectal cancers) [27] but a later study re-
ported that pre-diagnostic obesity increased hazard for
all cancers except cancers of the upper digestive tract
(obese compared to normal weight HR 0.87, 95% CI
0.62,1.22) [28]. More recently a North American study
[24] found recalled obesity in early adulthood was asso-
ciated with lower survival times than normal weight (HR
1.77, 95% CI 1.25, 2.51). The measure of obesity avail-
able in this study may not be optimal.
Exercise
We found that a 0.1 increase in probability of pre-
diagnosis physical activity outside of the workplace was
associated with improved survival (adjusted HR = 0.82,
95% CI 0.81,0.84). This is consistent with a recent review
[29] which found the relative risk of death between the
highest versus lowest category of physical activity to be
0.71 (95% CI 0.57,0.89) for esophageal cancer.
Strengths and weaknesses
Our analyses using estimated probability for health be-
haviors has produced results which have some face val-
idity. A strength of this example is that the data sets
used are large, public domain and well understood. Any
interested researcher can reproduce, refine and/or ex-
tend these analyses using the same data sets.
Both the data sets and the analysis technique used
have some limitations and weaknesses. In relation to the
data sets, there are response biases within the BRFSS
[30] which the sampling weights may not have fully ad-
dressed. Further, the measures of behavior available are
limited and are dictated by the existing data base which
was designed for other purposes and is not optimized
for our research question.
For the model, estimating the probability of a behavior
is less accurate than a direct measure of behavior and
conveys less information about that behavior: so will
have less power for detecting associations. There may be
residual confounding from unmeasured variables (such
as education, socio-economic status or comorbidities).
Table 3 Association Between Survival Time and Probability of Pre-Diagnosis Health Behavior; Esophageal Adenocarcinomas
1 year lag, unadjusted 1 year lag, adjustedb 10 year lag, adjustedb
Health behavior HRa 95% CI P value HRa 95% CI P value HRa 95% CI P value
Current smoker 1.00 0.98,1.01 0.625 1.20 1.18,1.23 < 0.001 1.18 1.16,1.21 < 0.001
Alcohol - Heavy drinking 0.55 0.51,0.59 < 0.001 0.85 0.77,0.93 < 0.001 1.10 0.95,1.26 0.216
Alcohol - Binge drinking 0.76 0.74,0.78 < 0.001 0.97 0.93,1.01 0.121 1.01 0.96,1.07 0.722
Current smoker and≥ 1 alcoholic drink /day 0.89 0.83,0.95 < 0.001 1.93 1.76,2.11 < 0.001 1.79 1.65,1.94 < 0.001
Did exercise in past 30 days other than regular job 0.78 0.77,0.80 < 0.001 0.82 0.81,0.84 < 0.001 0.83 0.81,0.85 < 0.001
Obese 0.94 0.92,0.96 < 0.001 1.03 1.00,1.05 0.028 1.07 1.04,1.10 < 0.001
Abbreviations: CI Confidence interval, HR Hazard ratio
aThe hazard ratio describes the impact of a 0.1 increase in the probability of having the specified health behavior
bAdjusted for age and cancer stage at diagnosis
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Finally, omitting interactions with year may have con-
tributed to the apparent lack of difference in outcomes
between behavior one, five and 10 years prior to
diagnosis.
Conclusion
The rarer the disease, the less feasible it is to conduct ei-
ther prospective cohort studies or record linkage (retro-
spective cohort) studies. Retrospective data collection
(including case-control studies) are fraught with recall
and survivor biases. Exploiting existing data provides
cost-effective opportunities for investigations but may
require different methodologies.
Analyses of the associations between estimated prob-
ability for pre-diagnosis health behavior (based on
demographic characteristics) and survival time in
esophageal cancer produced results with some face val-
idity. Expressing associations in units of changes in the
probability of the health behavior was cumbersome.
However, the required data are already available, allow-
ing relatively quick and inexpensive investigations of
possible associations between pre-diagnosis behavior
and post-diagnosis outcomes for relatively rare diseases.
And of course, most diseases are relatively rare.
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